| Immune checkpoint inhibition for hypermutant glioblastoma multiforme resulting from germline biallelic mismatch repair deficiency E Bouffet, V Larouche, BB Campbell, D Merico, R De Borja, M Aronson, ... Journal of clinical oncology 34 (19), 2206-2211, 2016 | 833 | 2016 |
| Comprehensive analysis of hypermutation in human cancer BB Campbell, N Light, D Fabrizio, M Zatzman, F Fuligni, R de Borja, ... Cell 171 (5), 1042-1056. e10, 2017 | 696 | 2017 |
| First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma LM Liau, K Ashkan, DD Tran, JL Campian, JE Trusheim, CS Cobbs, ... Journal of translational medicine 16, 1-9, 2018 | 535 | 2018 |
| Association of autologous tumor lysate-loaded dendritic cell vaccination with extension of survival among patients with newly diagnosed and recurrent glioblastoma: a phase 3 … LM Liau, K Ashkan, S Brem, JL Campian, JE Trusheim, FM Iwamoto, ... JAMA oncology 9 (1), 112-121, 2023 | 184 | 2023 |
| High levels of gadolinium deposition in the skin of a patient with normal renal function DR Roberts, SM Lindhorst, CT Welsh, KR Maravilla, MN Herring, ... Investigative radiology 51 (5), 280-289, 2016 | 159 | 2016 |
| Mechanisms and clinical significance of histone deacetylase inhibitors: epigenetic glioblastoma therapy P Lee, B Murphy, R Miller, V Menon, NL Banik, P Giglio, SM Lindhorst, ... Anticancer research 35 (2), 615-625, 2015 | 86 | 2015 |
| Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency A Das, S Sudhaman, D Morgenstern, A Coblentz, J Chung, SC Stone, ... Nature medicine 28 (1), 125-135, 2022 | 74 | 2022 |
| NRG Oncology/RTOG1205: a randomized phase II trial of concurrent bevacizumab and reirradiation versus bevacizumab alone as treatment for recurrent glioblastoma CI Tsien, SL Pugh, AP Dicker, JJ Raizer, MM Matuszak, EC Lallana, ... Journal of clinical oncology 41 (6), 1285-1295, 2023 | 64 | 2023 |
| A novel component from citrus, ginger, and mushroom family exhibits antitumor activity on human meningioma cells through suppressing the Wnt/β-catenin signaling pathway A Das, R Miller, P Lee, CA Holden, SM Lindhorst, J Jaboin, ... Tumor Biology 36, 7027-7034, 2015 | 56 | 2015 |
| Randomized phase II trial of re-irradiation and concurrent bevacizumab versus bevacizumab alone as treatment for recurrent glioblastoma (NRG Oncology/RTOG 1205): initial … C Tsien, S Pugh, AP Dicker, JJ Raizer, MM Matuszak, E Lallana, J Huang, ... International journal of radiation oncology, biology, physics 105 (1), S78, 2019 | 55 | 2019 |
| DNA polymerase and mismatch repair exert distinct microsatellite instability signatures in normal and malignant human cells J Chung, YE Maruvka, S Sudhaman, J Kelly, NJ Haradhvala, V Bianchi, ... Cancer discovery 11 (5), 1176-1191, 2021 | 54 | 2021 |
| Survival benefit for individuals with constitutional mismatch repair deficiency undergoing surveillance C Durno, AB Ercan, V Bianchi, M Edwards, M Aronson, M Galati, ... Journal of Clinical Oncology 39 (25), 2779-2790, 2021 | 52 | 2021 |
| RIP1 and RIP3 complex regulates radiation-induced programmed necrosis in glioblastoma A Das, DG McDonald, YN Dixon-Mah, DJ Jacqmin, VN Samant, ... Tumor Biology 37, 7525-7534, 2016 | 47 | 2016 |
| Synergistic effects of crizotinib and temozolomide in experimental FIG-ROS1 fusion-positive glioblastoma A Das, RR Cheng, MLT Hilbert, YN Dixon-Moh, M Decandio, ... Cancer growth and metastasis 8, CGM. S32801, 2015 | 33 | 2015 |
| Germline-driven replication repair-deficient high-grade gliomas exhibit unique hypomethylation patterns AJ Dodgshun, K Fukuoka, M Edwards, VJ Bianchi, A Das, A Sexton-Oates, ... Acta neuropathologica 140, 765-776, 2020 | 30 | 2020 |
| Ganoderic acid A/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth A Das, M Alshareef, F Henderson, JL Martinez Santos, WA Vandergrift, ... Clinical and Translational Oncology 22, 1138-1145, 2020 | 28 | 2020 |
| Functional repair assay for the diagnosis of constitutional mismatch repair deficiency from non-neoplastic tissue AY Shuen, S Lanni, GB Panigrahi, M Edwards, L Yu, BB Campbell, ... Journal of Clinical Oncology, 461-470, 2019 | 28 | 2019 |
| Adult immuno-oncology: using past failures to inform the future M Rahman, WG Sawyer, S Lindhorst, LP Deleyrolle, JK Harrison, ... Neuro-oncology 22 (9), 1249-1261, 2020 | 24 | 2020 |
| Current studies of immunotherapy on glioblastoma NS Agrawal, R Miller Jr, R Lal, H Mahanti, YN Dixon-Mah, ML DeCandio, ... Journal of neurology and neurosurgery 1 (1), 2014 | 22 | 2014 |
| Life without mismatch repair MA Sanders, H Vöhringer, VJ Forster, L Moore, BB Campbell, Y Hooks, ... bioRxiv, 2021.04. 14.437578, 2021 | 21 | 2021 |
